Mary Jane Raymond
Analyst · Christopher Longiaru from Sidoti & Company
Thank you, Fran and Chuck. As you can see from our press release and what you’ve just heard from Fran and Chuck, we will have news today. The results really speak for themselves. So I'll just hit the highlights for you. In fiscal year 2016, we had organic bookings growth of $100 million. Our gross margin expanded 120 basis points to 37.8% for the year and our full-year organic or non-GAAP return on sales exceeded 10%. The major difference in our results between GAAP and non-GAAP is the effect of the acquisitions and divestitures. This includes the operating losses and the one-time costs to acquire and restructure two new companies. Together, the acquisitions were dilutive by $0.29 for the year, $0.17 in Q4 and $0.12 in Q3. The sale of the RF commercial assets reduces the ongoing operating losses considerably. Apart from the $0.29 just mentioned, we had several entries to close year-end in both our GAAP and non-GAAP results. These collectively, not including the $0.29, don't have a material effect on the EPS in the quarter. They include a $0.14 per share, non-cash tax valuation reserve arising from the combination of the new acquisitions, the purchase accounting and the divestitures, all being incorporated into our total company consolidated results. This is why you will see an unusual tax rate in the quarter of 49% and for the year, a rate of 27%. For next year, FY17, we expect the tax rate in the mid-20s. Other reserve changes in the fourth quarter to offset this include a reduction in our inventory reserve based on the inventory usage in the fourth quarter to meet the demand, that's worth about $0.04. A reduction in expense for that portion of our equity-based compensation, that is evaluated, based on the June 30 ending stock price. That is $0.05 and a reduction in our professional services expenses of another $0.03. So the entries affecting our reserves, inventory access and obsolescence, the equity-based comp and professional services are the group that as I say collectively don't have a material effect. Our book-to-bill was 1.01 for Q4 and 1.06 for the full year. Our backlog is $298 million, consisting of 76 in Laser Solutions, 114 in Photonics and 100 million in Performance Products. The 76 million for laser solutions is already reduced for the 13 million of backlog that was divested. All segments made meaningful progress this quarter on their non-GAAP operating margins, especially laser solutions at 26%, helped by the recovering yen as well as additional revenue. We renewed our credit facility this quarter to expand our liquidity and supplement our cash. We expanded the facility to $425 million, supplementing our 218 million in cash. The facility has a five-year term. Our current debt is $236 million and our net debt position is 18 million. With $26 million in CapEx this quarter and 58 million for the year, for next year, fiscal year ‘17, we expect capital to be close to $100 million, driven by new investments and capacity expansion. We had $9.7 million in share-based comp for the year and we repurchased 6 million shares of our stock -- $6 million worth of our stock. For FY17, we expect share-based compensation to be between 14 million and 16 million higher than our normal 12 million to 14 million. This is because in FY17, we’ll grant equity to a broader group of employees, something we've done in the past in II-VI just about kind of every four years. We have $31 million remaining on our 50 million share buyback and we expect, at this time, to buyback our dilution. The outlook for fiscal year ended September 30, 2016 is revenue of 210 million to 225 million and earnings per share of $0.22 to $0.27. Included in this range is the increased R&D platform investment of around $0.10 a share for the quarter. This is all at prevailing exchange rates and all earnings per share data refer to diluted shares. Comparable results for the quarter ended September 30, 2015, so last year's first quarter were revenues of 189.2 million and diluted earnings per share of $0.27. As discussed in more detail below, actual results may differ from these forecasts due to a variety of factors, including but not limited to changes in product demand, changes in customer forecast, competition and general economic conditions. From a marketing perspective, we’re widening the range we had published for FY16 to accommodate in FY17 the R&D platform investments and to anticipate any potential changes that might occur in the current strength of the optical communications market. The expected average annual ranges are for the year, not necessarily for every quarter. The gross margin range is 35% to 39%, the EBITDA range is 16% to 20% and the op income range is 7% to 10%. Again, going forward, the actual results may differ from these forecasts due to a whole variety of factors, not limited to the ones I just mentioned. Before I ask Chuck to make our concluding remarks today, I’ll just let you know that our first quarter earnings release date is slated for Tuesday, October 26, 2016. Chuck?